Cullinan Associates Inc. purchased a new stake in Lam Research Corporation (NASDAQ:LRCX – Free Report) in the first quarter, Holdings Channel.com reports. The fund purchased 64,500 shares of the semiconductor company’s stock, valued at approximately $13,781,000. Lam Research makes up about 1.1% of Cullinan Associates Inc.’s holdings, making the stock its 22nd biggest holding.
Other large investors have also bought and sold shares of the company. Fideuram Asset Management Ireland dac purchased a new stake in Lam Research in the 4th quarter valued at about $10,035,000. Generali Investments Management Co LLC boosted its stake in shares of Lam Research by 62.0% in the 4th quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company’s stock worth $6,209,000 after buying an additional 13,878 shares during the last quarter. Krilogy Financial LLC grew its holdings in shares of Lam Research by 19.5% in the first quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock valued at $6,006,000 after acquiring an additional 4,584 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Lam Research in the first quarter valued at approximately $26,489,000. Finally, Whalen Wealth Management Inc. purchased a new stake in shares of Lam Research during the fourth quarter valued at approximately $1,423,000. 84.61% of the stock is currently owned by institutional investors.
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Mizuho raised its price target on Lam Research to $400 from $380 and kept an outperform rating, adding to the bullish analyst momentum around the stock.
- Positive Sentiment: Stifel Nicolaus boosted its target to $425 from $325 and reiterated a buy rating, citing above-consensus estimates and suggesting further upside for LRCX.
- Positive Sentiment: Needham also increased its target to $390 from $300 and maintained a buy rating, reinforcing the view that Lam Research is well positioned to benefit from AI-driven chip demand.
- Positive Sentiment: Additional coverage highlighted Lam Research as a beneficiary of broader AI infrastructure spending and possible easing of China-related chip restrictions, which could improve sentiment across semiconductor equipment names. Does AI Rebound and China Chip Access Shift Change The Bull Case For Lam Research (LRCX)?
- Neutral Sentiment: Lam Research announced that it will host its June quarter financial conference call and webcast on July 29, giving investors a near-term catalyst to watch.
- Neutral Sentiment: Short-interest data showed no meaningful change, with reported short interest at zero shares, so it does not appear to be a factor driving the move.
Lam Research Stock Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.11. The company had revenue of $5.84 billion for the quarter, compared to analyst estimates of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The company’s quarterly revenue was up 23.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Equities analysts anticipate that Lam Research Corporation will post 5.68 earnings per share for the current year.
Lam Research Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th were given a dividend of $0.26 per share. The ex-dividend date was Wednesday, June 17th. This represents a $1.04 annualized dividend and a dividend yield of 0.3%. Lam Research’s dividend payout ratio is currently 19.62%.
Insiders Place Their Bets
In related news, Director Eric Brandt sold 54,500 shares of the business’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the sale, the director directly owned 199,205 shares in the company, valued at approximately $69,881,114. The trade was a 21.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 6,010 shares of the firm’s stock in a transaction dated Monday, April 27th. The stock was sold at an average price of $258.66, for a total value of $1,554,546.60. Following the completion of the transaction, the insider owned 53,205 shares of the company’s stock, valued at approximately $13,762,005.30. This represents a 10.15% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 86,339 shares of company stock worth $27,680,267 over the last 90 days. Corporate insiders own 0.31% of the company’s stock.
Wall Street Analyst Weigh In
LRCX has been the topic of a number of recent analyst reports. Cantor Fitzgerald set a $500.00 price target on Lam Research and gave the stock an “overweight” rating in a report on Monday, June 29th. Royal Bank Of Canada raised their target price on Lam Research from $290.00 to $310.00 and gave the company an “outperform” rating in a research report on Thursday, April 23rd. Weiss Ratings cut Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a research note on Thursday, May 14th. Berenberg Bank boosted their price target on shares of Lam Research from $265.00 to $335.00 and gave the stock a “buy” rating in a report on Thursday, April 23rd. Finally, TD Cowen restated a “buy” rating and set a $400.00 price target (up from $340.00) on shares of Lam Research in a research report on Thursday. Twenty-eight research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Lam Research has an average rating of “Moderate Buy” and an average target price of $350.81.
View Our Latest Analysis on Lam Research
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More
- Five stocks we like better than Lam Research
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
- Why “Big Short” Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
